|
|
Other links at Articles > Rheumatology |
| 3. |
Adalimumab and Etanercept Edge Infliximab in RA Therapy
|
|
|
Among tumor necrosis factor alpha blockers, adalimumab and etanercept appear to be more effective and less expensive than infliximab for treatment of patients with rheumatoid arthritis (RA), Dutch researchers report in the September issue of Annals of the Rheumatic Diseases. Reuters Health Information
|
|
|
